Whole Blood Filtration System - China

Blood Transfusion System

Filtration System

For whole blood collection and in-line -filtration of whole blood components, obtaining leucoreduced red blood cells and leucoreduced plasma through the process of centrifugation and extraction.

Imported Film

Ultra Sharp Needle

Customized Accessories

Reduction Rate 99.99%

Residual Leukocyte <1.0*106/unit

Red Blood Cell Recovery ≥90%

<1.0*106 leukocytes per unit

<0.8% hemolysis

>85% red cell recovery

< 30min filtration time

Company Contact:

• Posted By: Shanghai Xingliao Trading Co.,Ltd.

• Phone: +86-21-52826603

• Address: Room 5C,5th Floor,No.427 Nujiang North Road,Putuo District,Shanghai,China., Shanghai , Shanghai , China

• Email:

• Website: https://www.fosmedic.com

• Business Description: Shanghai Xingliao Trading Co., Ltd.(Registered Main Brand : Fosmedic? ) also known as Fosmedic is a professional supplier for manufacturing and exporting disposable medical devices.
  
  The main products include surgical sutures, surgical blades, blood transfusion bags, transfusion sets, leukocyte filters and other medical supplies.
  
  It operates several reputable manufacturing plants located in Shanghai and Jiangsu respectively.
  
  All exported products have passed the CE and ISO certification.
  
  Recently the products have been distributed to over 40 countries and regions in Asia, Europe, Middle East, Africa, Oceania, North and South America.
  
  1st Class Quality, competitive pricing policy, perfect service system, and innovative technology has helped our products to be well recognized by global medical dealers, hospitals, blood banks, labs and clinics, as well as the health ministry of many countries and the Red Cross.
  
  Looking to the future, Fosmedic will continue to shoulder its social responsibilities, paying attention to the organization of personnel and team building, integrating medical industry resources, and finally improving its core competence to accomplish its strategic target of being a first-class enterprise in the global mainstream markets.